基底动脉闭塞晚期血管内再通疗效与侧支循环状态相关
本研究回顾性分析多中心172例接受血管内治疗的基底动脉闭塞患者,评估侧支循环和血栓负荷是否影响再通、治疗时间与预后的关联。结果显示再通与良好预后相关,且此关联在侧支循环良好患者中不受治疗时间超过6小时影响。
要点
- 再通与良好预后相关,侧支循环良好者即使超过6小时再通仍可获益。
- BATMAN或PC-CS评分良好者再通与良好预后独立相关。
- 侧支循环不良者早期(≤6小时)再通与良好预后相关,晚期则无此关联。
核心结论
- 再通与基底动脉闭塞患者良好预后相关,侧支循环良好且闭塞范围较小者即使发病超过6小时仍可获益。
研究设计与样本
- 回顾性分析多中心基底动脉治疗与管理协作组中连续接受血管内治疗的基底动脉闭塞患者172例,其中124例接受机械取栓。
主要发现
- 再通(79%患者实现)与良好预后相关(P=0.003),使用新一代取栓装置亦与良好预后相关(P=0.03)。
- 再通患者中,BATMAN评分良好者29/46(63%)预后良好,PC-CS评分良好者26/51(51%)预后良好。
- 调整年龄、NIHSS评分和治疗时间后,再通与良好预后的关联在BATMAN评分良好者(OR 15.8,95%CI 1.4-175,P=0.02)和PC-CS评分良好者(OR 9.4,95%CI 1.4-64,P=0.02)中显著。
- 再通患者中,BATMAN评分不良者早期治疗(≤6小时)与良好预后相关(18/52 [35%];OR 15,95%CI 1.9-124,P=0.01),晚期治疗无此关联。
- 再通患者中,PC-CS评分不良者早期治疗与良好预后相关(16/44 [36%];OR 5.5,95%CI 1.4-21,P=0.01),晚期治疗无此关联。
临床怎么用
- 对于基底动脉闭塞患者,评估侧支循环(如BATMAN、PC-CS评分)有助于筛选可从晚期血管内再通中获益的人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- The benefit of endovascular therapy in extended time windows has been demonstrated in patients with anterior circulation large vessel occlusion ischemic stroke and favorable imaging profile. We evaluated whether collaterals and thrombus burden influence the associations between revascularization, time-to-treatment, and outcome in endovascular therapy-treated patients with basilar artery occlusion. Methods- We retrospectively analyzed clinical and imaging data of consecutive endovascular therapy-treated patients with basilar artery occlusion included in the multicenter Basilar Artery Treatment and Management Collaboration. The BATMAN (Basilar Artery on Computed Tomography Angiography score, which evaluates thrombus burden and collaterals) and the PC-CS (Posterior Circulation Collateral score, which evaluates collaterals) were assessed on computed tomography angiography, blinded to clinical outcome. Good outcome was defined as modified Rankin Scale score of ≤3 within 3 months; revascularization (successful reperfusion) as modified Thrombolysis in Cerebral Infarction 2b-3 (or TIMI [Thrombolysis in Myocardial Infarction] 2-3 in the BASICS [Basilar Artery International Cooperation Study] registry). Results- We included 172 patients with basilar artery occlusion treated with endovascular therapy (124 with mechanical thrombectomy): mean (SD) age 65 (13) years, median National Institutes of Health Stroke Scale 22 (interquartile range 12-30), 64 (37%) treated >6 hours. Revascularization (achieved in 79% of patients) was associated with good outcome (P=0.003). The use of new generation thrombectomy devices was associated with good outcome (P=0.03). In patients who achieved revascularization, 29/46 (63%) of patients with a favorable BATMAN score and 26/51 (51%) with favorable PC-CS had good outcomes. In logistic regression analysis (adjusted for age, National Institutes of Health Stroke Scale, and time-to-treatment ≤6/>6 hours), revascularization was associated with good outcome in patients with favorable BATMAN score (odds ratio, 15.8; 95% CI, 1.4-175; P=0.02) or PC-CS (odds ratio, 9.4; 95% CI, 1.4-64; P=0.02). In patients who achieved revascularization, early (time-to-treatment ≤6 hours) but not late treatment was associated with improved outcome in patients with unfavorable BATMAN score (18/52 [35%]; odds ratio, 15; 95% CI, 1.9-124; P=0.01) or PC-CS (16/44 [36%]; odds ratio, 5.5; 95% CI, 1.4-21; P=0.01). Conclusions- Revascularization is associated with good outcome in patients with basilar artery occlusion with good collaterals and less extensive occlusion, even >6 hours after onset.
引用
- Alemseged F, Van der Hoeven E, Di Giuliano F, et al. Response to Late-Window Endovascular Revascularization Is Associated With Collateral Status in Basilar Artery Occlusion. Stroke. 2019. PMID: 31092168. doi:10.1161/STROKEAHA.118.023361
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。